Russia announces world's first Covid-19 vaccine.

Amid the race to develop a Covid-19 vaccine, Russian President Vladimir Putin launched a coronavirus vaccine, touted as the world's first such vaccine, too. The registration of the vaccine lays ground for...

Russia's COVID-19 vaccine to enter production, deliver first batch of doses in two weeks.

The world’s first vaccine registered by Russian authorities, and now the World Health Organisation has said it is in talks with Russia's health ministry for a thorough review of the safety and efficacy..

Moderna Announces Supply Agreement with U.S. Government for Initial 100 Million Doses of mRNA Vaccine Against COVID-19.

Moderna, Inc., a biotechnology company announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S. government...

Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2.

Pfizer Inc. and BioNTech SE announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development program...

Glenmark introduces higher strength (400 mg) of FabiFlu to reduce pill burden of COVID-19 treatment.

Glenmark Pharmaceutical announced that it will introduce a 400 mg version of oral antiviral FabiFlu, for the treatment of mild to moderate COVID-19 in India.

Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-1.

Pfizer Inc. announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead's investigational antiviral remdesivir, as one of multiple external manufacturing organizations...

U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19.

Grand River Aseptic Manufacturing has been selected by the U.S. Department of Health and Human Services and the U.S. Department of Defense to support the expansion of the United States capacity...

Gilead Submits New Drug Application to U.S. FDA for Veklury for the Treatment of COVID-19.

Gilead Sciences, Inc. announced that it has submitted a NDA to the U.S. FDA for Veklury, an investigational antiviral for the treatment of patients with COVID-19. Veklury is currently available in the U.S. under...